Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-YL]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
    2.
    发明授权
    Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-YL]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process 有权
    制备3 - [(4S)-8-溴-1-甲基-6-(2-吡啶基)-4H-咪唑并[1,2-A] [1,4]苯并二氮杂-4-YL]丙酸甲酯 酯或其苯磺酸盐,以及可用于该方法的化合物

    公开(公告)号:US09156842B2

    公开(公告)日:2015-10-13

    申请号:US13496742

    申请日:2010-09-15

    摘要: The invention concerns a new process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-a][1,4]benzodiazepine-4-yl]-propionic acid methyl ester or 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester benzene sulfonate (P) which comprises reacting 3-[(S)-7-bromo-2-((R and/or S)-2-hydroxy-propylamino)-5-pyridin-2-yl-3H-benzo[e][1,4]diazepin-3-yl]-propionic acid methyl ester of formula (EM) with an oxidizing agent and optionally treating the reaction product under acidic conditions, such as to produce the compound of formula (F) or the compound (P), and new compounds useful as starting material or as intermediate for performing that process.

    摘要翻译: 本发明涉及一种制备3 - [(4S)-8-溴-1-甲基-6-(2-吡啶基)-4H-咪唑并[1,2-a] [1,4]苯并二氮杂- 吡啶-3-基] - 丙酸甲酯或3 - [(4S)-8-溴-1-甲基-6-(2-吡啶基)-4H-咪唑并〔1,2-a〕〔1,4〕苯并二氮杂-4- 吡啶-2-基]丙酸甲酯苯磺酸盐(P),其包括使3 - [(S)-7-溴-2 - ((R和/或S)-2-羟基 - 丙基氨基) -3H-苯并[e] [1,4]二氮杂-3-基] - 丙酸甲酯与氧化剂反应,并在酸性条件下任选地处理反应产物,例如制备式 (F)或化合物(P),以及可用作原料的新化合物或用于进行该方法的中间体。

    Orally active iron (III) chelators
    4.
    发明授权
    Orally active iron (III) chelators 有权
    口服活性铁(III)螯合剂

    公开(公告)号:US06448273B1

    公开(公告)日:2002-09-10

    申请号:US09451112

    申请日:1999-11-30

    IPC分类号: A61K314412

    摘要: A compound of formula I wherein R is hydrogen or a group that is removed by metabolism in vivo to provide the free hydroxy compound, R1 is an aliphatic hydrocarbon group or an aliphatic hydrocarbon group substituted by a hydroxy group or a carboxylic acid ester, sulpho acid ester or a C1-6 alkoxy, C6-aryloxy or C7-10aralkoxy ether thereof, and R3 is selected from hydrogen and C1-6 alkyl; characterized in that R2 is selected from groups (i) —CONH—R5 (ii)—CR6R6OR7 (iii) —CONHCOR5 and (iv) —CON(CnH2n+1)2 R4 is selected from hydrogen, C1-6 alkyl and a group as described for R2; R5 is selected from hydrogen and optionally hydroxy, alkoxy, aryloxy or aralkoxy substituted C1-13 alkyl, aryl and C7-13 alkyl R6 is independently selected from hydrogen and C1-13 alkyl, R7 is selected from hydrogen, C1-13 alkyl, aryl and C7-13 aralkyl or a pharmaceutically acceptable salt of any such compound and CnH2n+1 is C1-6alkyl with the proviso that the compound is not one of 1-ethyl-2-(1′-hydroxyethyl)-3-hydroxypyridin-4-one and 1-methyl-2-hydroxymethyl-3-hydroxypyridoin-4-one.

    摘要翻译: 式I化合物,其中R是氢或通过体内代谢除去以提供游离羟基化合物的基团,R 1是脂族烃基或被羟基或羧酸酯取代的脂族烃基,磺酸酯或 C 1-6烷氧基,C 6芳氧基或C 7-10芳烷氧基醚,R 3选自氢和C 1-6烷基;其特征在于R 2选自(ⅰ)-CONH-R5(ⅱ)-CR6R6OR7(ⅲ) - CONHCOR 5和(iv)-CON(C n H 2n + 1)2 R 4选自氢,C 1-6烷基和如对R 2所述的基团; R 5选自氢和任选的羟基,烷氧基,芳氧基或芳烷氧基取代的C 1-13烷基, 芳基和C7-13烷基R6独立地选自氢和C1-13烷基,R7选自氢,C1-13烷基,芳基和C7-13芳烷基或任何这样的化合物的药学上可接受的盐,C n H 2n + 1是C 1-6烷基, 条件是该化合物不是1-乙基-2-(1'-羟乙基)-3-羟基吡啶-4中的一种 - 酮和1-甲基-2-羟甲基-3-羟基吡啶-4-酮。

    PROCESS FOR PREPARING 3-[(4S)-8-BROMO-1-METHYL-6-(2-PYRIDINYL)-4H-IMIDAZO[1,2-A][1,4]BENZODIAZEPINE-4-YL]PROPIONIC ACID METHYL ESTER OR THE BENZENE SULFONATE SALT THEREOF, AND COMPOUNDS USEFUL IN THAT PROCESS
    5.
    发明申请
    PROCESS FOR PREPARING 3-[(4S)-8-BROMO-1-METHYL-6-(2-PYRIDINYL)-4H-IMIDAZO[1,2-A][1,4]BENZODIAZEPINE-4-YL]PROPIONIC ACID METHYL ESTER OR THE BENZENE SULFONATE SALT THEREOF, AND COMPOUNDS USEFUL IN THAT PROCESS 有权
    制备3 - [(4S)-8-溴-1-甲基-6-(2-吡啶基)-4H-咪唑并[1,2-A] [1,4]苯并噻吩并[4-y]]丙酸甲酯的方法 ESTER或其中的苯甲磺酸盐及其用途的化合物

    公开(公告)号:US20150368199A1

    公开(公告)日:2015-12-24

    申请号:US14841899

    申请日:2015-09-01

    IPC分类号: C07D213/50

    摘要: The invention concerns a new process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-a][1,4]benzodiazepine-4-yl]-propionic acid methyl ester or 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester benzene sulfonate (P) which comprises reacting 3-[(S)-7-bromo-2-((R and/or S)-2-hydroxy-propylamino)-5-pyridin-2-yl-3H-benzo[e][1,4]diazepin-3-yl]-propionic acid methyl ester of formula (EM) with an oxidizing agent and optionally treating the reaction product under acidic conditions, such as to produce the compound of formula (F) or the compound (P), and new compounds useful as starting material or as intermediate for performing that process.

    摘要翻译: 本发明涉及一种制备3 - [(4S)-8-溴-1-甲基-6-(2-吡啶基)-4H-咪唑并[1,2-a] [1,4]苯并二氮杂- 吡啶-3-基] - 丙酸甲酯或3 - [(4S)-8-溴-1-甲基-6-(2-吡啶基)-4H-咪唑并〔1,2-a〕〔1,4〕苯并二氮杂-4- 吡啶-2-基]丙酸甲酯苯磺酸盐(P),其包括使3 - [(S)-7-溴-2 - ((R和/或S)-2-羟基 - 丙基氨基) -3H-苯并[e] [1,4]二氮杂-3-基] - 丙酸甲酯与氧化剂反应,并在酸性条件下任选地处理反应产物,例如制备式 (F)或化合物(P),以及可用作原料的新化合物或用于进行该方法的中间体。

    PROCESS FOR PREPARING 3-[(4S)-8-BROMO-1-METHYL-6-(2-PYRIDINYL)-4H-IMIDAZO[1,2-A][1,4]BENZODIAZEPINE-4-YL]PROPIONIC ACID METHYL ESTER OR THE BENZENE SULFONATE SALT THEREOF, AND COMPOUNDS USEFUL IN THAT PROCESS
    9.
    发明申请
    PROCESS FOR PREPARING 3-[(4S)-8-BROMO-1-METHYL-6-(2-PYRIDINYL)-4H-IMIDAZO[1,2-A][1,4]BENZODIAZEPINE-4-YL]PROPIONIC ACID METHYL ESTER OR THE BENZENE SULFONATE SALT THEREOF, AND COMPOUNDS USEFUL IN THAT PROCESS 有权
    制备3 - [(4S)-8-溴-1-甲基-6-(2-吡啶基)-4H-咪唑并[1,2-A] [1,4]苯并噻吩-4-基]丙酸甲酯的方法 ESTER或其中的苯甲磺酸盐及其用途的化合物

    公开(公告)号:US20120330007A1

    公开(公告)日:2012-12-27

    申请号:US13496742

    申请日:2010-09-15

    IPC分类号: C07D487/06 C07D211/70

    摘要: The invention concerns a new process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-a][1,4]benzodiazepine-4-yl]-propionic acid methyl ester or 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester benzene sulfonate (P) which comprises reacting 3-[(S)-7-bromo-2-((R and/or S)-2-hydroxy-propylamino)-5-pyridin-2-yl-3H-benzo[e][1,4]diazepin-3-yl]-propionic acid methyl ester of formula (EM) with an oxidizing agent and optionally treating the reaction product under acidic conditions, such as to produce the compound of formula (F) or the compound (P), and new compounds useful as starting material or as intermediate for performing that process.

    摘要翻译: 本发明涉及一种制备3 - [(4S)-8-溴-1-甲基-6-(2-吡啶基)-4H-咪唑并[1,2-a] [1,4]苯并二氮杂- 吡啶-3-基] - 丙酸甲酯或3 - [(4S)-8-溴-1-甲基-6-(2-吡啶基)-4H-咪唑并〔1,2-a〕〔1,4〕苯并二氮杂-4- 吡啶-2-基]丙酸甲酯苯磺酸盐(P),其包括使3 - [(S)-7-溴-2 - ((R和/或S)-2-羟基 - 丙基氨基) -3H-苯并[e] [1,4]二氮杂-3-基] - 丙酸甲酯与氧化剂反应,并在酸性条件下任选地处理反应产物,例如制备式 (F)或化合物(P),以及可用作原料的新化合物或用于进行该方法的中间体。